Skip to content
MARKETS / NASDAQ / GDRX
NASDAQ · SERVICES-COMPUTER PROCESSING & DATA PREPARATION · MID CAP

GoodRx Holdings, Inc. GDRX

8 fiscal years on record · USD · FY2025 reported · SEC filings only
$796.9M
▲ 0.6% YoY
$30.4M
▲ 85.7% YoY
$164.4M
▼ 10.0% YoY
In brief

What this company does

GoodRx Holdings, Inc. operates a price comparison platform for prescriptions that processes over 420 billion pricing data points every day, providing consumers with dynamic, geographically relevant prescription pricing and access to negotiated prices through GoodRx codes across the United States. As of December 31, 2025, it employed 697 employees, all of which are full-time employees. Its prescription marketplace consists of a prescription transactions offering and supplemental subscription and telehealth offerings. Through the prescription transactions offering, the company earns revenue upon the initial usage of a GoodRx code when a consumer realizes savings compared to the list price at the pharmacy, and continues to earn revenue when the consumer returns to the pharmacy for refills and new prescriptions. Its subscription offerings provide additional benefits to consumers of the prescription transactions offering, including increased discounts on prescription prices, discounted virtual care visits, or free home delivery on eligible medications, with the Gold program requiring subscribers to generally pay a monthly or annual fee for access to lower prices at select participating pharmacies. Pharma manufacturers provide affordability solutions such as co-pay cards, patient assistance programs, consumer direct pricing, care portals, and other savings options, and the company partners with pharma manufacturers to advertise and integrate these affordability solutions into its platform. GoodRx Holdings, Inc., a Delaware corporation, was incorporated in September 2015, having initially been formed in September 2011 as GoodRx, Inc., a Delaware corporation that is now its indirect subsidiary.

Written from the business description in GoodRx Holdings, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 26 February 2026. Every sentence was checked against that document before publication.

Growth
USD 796.9M
Revenue, FY2025 · full 8-year series below
Revenue $M Net income $M
FY2025 · Revenue 796.9 · Net income 30.4
400M-100M-200M20182019202020212022202320242025
Compound annual growth
+1.3%
+7.7%
+32.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +7.7% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
4 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 11.0% · Net 3.8%
10%20%30%-20%-40%20182019202020212022202320242025
ROE
FY2025 · ROE 4.5%
2%4%-1%-2%-3%20182019202020212022202320242025

Each USD of equity produced 5 cents of profit this year.

Cash & shareholders
USD 216.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 164.4
80M160M20182019202020212022202320242025
Net buybacks $B Dividends $B
FY2025 · Dividends — · Net buybacks 0.2
0.5B1.0B2018202020212022202320242025

USD 216.3M in buybacks — 711% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 1.4B
EquityUSD 616.3M
CashUSD 261.8M
Gross debtUSD 488.3M
Net debtUSD 226.4M
Current ratio2.61×

Net debt stands at 37% of equity.

The 8-year record
8 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018
Revenue $B0.80.80.80.80.70.60.40.2
Operating income $B0.10.1−0.00.00.0−0.30.10.1
EBITDA $B0.10.1−0.00.00.0−0.30.10.1
Income tax $B0.00.0−0.00.00.0−0.00.00.0
Net income $B0.00.0−0.0−0.0−0.0−0.30.10.0
Free cash flow $B0.20.20.10.10.20.10.10.0
EPS, diluted $0.090.04−0.02−0.08−0.06−1.070.180.12
Dividend / sh $········
Payout %·······3074
ROE %4.52.2−1.1−4.0−3.3···

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 30 reconciliationsAUDITED

Reconciled in 8 of 19 fiscal years. 57 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Computer Processing & Data Preparation
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2018

Share this section

Download image